Intervention Protocol

TNF-alpha inhibitors for ankylosing spondylitis

  1. Jane Zochling1,*,
  2. Lara Maxwell2,
  3. Jil Beardmore2,
  4. Annelies Boonen3

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 20 JUL 2005

DOI: 10.1002/14651858.CD005468

How to Cite

Zochling J, Maxwell L, Beardmore J, Boonen A. TNF-alpha inhibitors for ankylosing spondylitis (Protocol). Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD005468. DOI: 10.1002/14651858.CD005468.

Author Information

  1. 1

    Menzies Research Institute, Hobart, Tasmania, Australia

  2. 2

    University of Ottawa, Institute of Population Health, Ottawa, Ontario, Canada

  3. 3

    Caphri Research Institute, Department of Rheumatology, 6202 AZ Maastricht, Netherlands

*Jane Zochling, Menzies Research Institute, Private Bag 23, Hobart, Tasmania, 7001, Australia.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JUL 2005


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.